# Integra LifeSciences to acquire Derma Sciences for $7.00 per share

Integra LifeSciences has signed a definitive agreement to acquire Derma Sciences for $7.00 per share in cash, expanding its regenerative technology and advanced wound care capabilities. The transaction is expected to close at the end of Q1 2017.

- Type: Acquisition
- Announced: 2017-01-10
- Where: United States
- Value: $204.0M
- Status: announced
- Products: amniotic tissue-based products, advanced wound care products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Integra LifeSciences](https://endata.com/companies/21365.md) (acquirer)
- [Derma Sciences](https://endata.com/companies/21366.md) (target)

## Sources

- [globenewswire.com](https://www.globenewswire.com/de/news-release/2017/01/11/904959/1063/en/Integra-LifeSciences-to-Acquire-Derma-Sciences-Inc-and-Announces-Preliminary-Fourth-Quarter-and-Full-Year-2016-Financial-Results-and-2017-Outlook.html), 2017-01-11: "Integra LifeSciences Holdings Corporation announced today that it has signed a definitive agreement to acquire Derma Sciences Inc."
- [biospace.com](https://www.biospace.com/integra-lifesciences-scoops-up-derma-sciences-in-204-million-deal), 2017-01-11: "Integra LifeSciences Holdings Corporation announced today that it has signed a definitive agreement to acquire Derma Sciences Inc. for a price of $7.00 per share."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.